According to a report in Live Mint which quoted data from VCCEdge, outbound mergers and acquisitions in the healthcare sector in India were worth $1.5 billion in 2015 as against $251 million in 2014. Outbound Acquisitions Acquirer Acquiree Deal Size Lupin, India Gavis Pharmaceuticals, U.S. $880 million Cipla, India InvaGen...
Two India-based companies launch Malaria drug for India and the world
India's Cipla and Ranbaxy Laboratories (owned by Japan's Daiichi Sankyo) both announced novel combination therapies for on World Malaria Day — with eyes on markets in India, Africa, South America and Southeast Asia. The products — Ranbaxy’s Synriam and Cipla’s Meflian Plus — are combinations of existing molecules arterolane maleate...